Literature DB >> 18852061

Replacing Escherichia coli NAD-dependent glyceraldehyde 3-phosphate dehydrogenase (GAPDH) with a NADP-dependent enzyme from Clostridium acetobutylicum facilitates NADPH dependent pathways.

Irene Martínez1, Jiangfeng Zhu, Henry Lin, George N Bennett, Ka-Yiu San.   

Abstract

Reactions requiring reducing equivalents, NAD(P)H, are of enormous importance for the synthesis of industrially valuable compounds such as carotenoids, polymers, antibiotics and chiral alcohols among others. The use of whole-cell biocatalysis can reduce process cost by acting as catalyst and cofactor regenerator at the same time; however, product yields might be limited by cofactor availability within the cell. Thus, our study focussed on the genetic manipulation of a whole-cell system by modifying metabolic pathways and enzymes to improve the overall production process. In the present work, we genetically engineered an Escherichia coli strain to increase NADPH availability to improve the productivity of products that require NADPH in its biosynthesis. The approach involved an alteration of the glycolysis step where glyceraldehyde-3-phosphate (GAP) is oxidized to 1,3 bisphophoglycerate (1,3-BPG). This reaction is catalyzed by NAD-dependent endogenous glyceraldehyde-3-phosphate dehydrogenase (GAPDH) encoded by the gapA gene. We constructed a recombinant E. coli strain by replacing the native NAD-dependent gapA gene with a NADP-dependent GAPDH from Clostridium acetobutylicum, encoded by the gene gapC. The beauty of this approach is that the recombinant E. coli strain produces 2 mol of NADPH, instead of NADH, per mole of glucose consumed. Metabolic flux analysis showed that the flux through the pentose phosphate (PP) pathway, one of the main pathways that produce NADPH, was reduced significantly in the recombinant strain when compared to that of the parent strain. The effectiveness of the NADPH enhancing system was tested using the production of lycopene and epsilon-caprolactone as model systems using two different background strains. The recombinant strains, with increased NADPH availability, consistently showed significant higher productivity than the parent strains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852061     DOI: 10.1016/j.ymben.2008.09.001

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  33 in total

Review 1.  Systems metabolic engineering of microorganisms for natural and non-natural chemicals.

Authors:  Jeong Wook Lee; Dokyun Na; Jong Myoung Park; Joungmin Lee; Sol Choi; Sang Yup Lee
Journal:  Nat Chem Biol       Date:  2012-05-17       Impact factor: 15.040

2.  Lipid production in Yarrowia lipolytica is maximized by engineering cytosolic redox metabolism.

Authors:  Kangjian Qiao; Thomas M Wasylenko; Kang Zhou; Peng Xu; Gregory Stephanopoulos
Journal:  Nat Biotechnol       Date:  2017-01-16       Impact factor: 54.908

Review 3.  Redox cofactor engineering in industrial microorganisms: strategies, recent applications and future directions.

Authors:  Jiaheng Liu; Huiling Li; Guangrong Zhao; Qinggele Caiyin; Jianjun Qiao
Journal:  J Ind Microbiol Biotechnol       Date:  2018-03-27       Impact factor: 3.346

4.  Metabolic engineering of Corynebacterium glutamicum for increasing the production of L-ornithine by increasing NADPH availability.

Authors:  Ling-Yan Jiang; Yuan-Yuan Zhang; Zhen Li; Jian-Zhong Liu
Journal:  J Ind Microbiol Biotechnol       Date:  2013-07-09       Impact factor: 3.346

5.  Enhancement of NADPH availability for coproduction of coenzyme Q10 and farnesol from Rhodobacter sphaeroides.

Authors:  Man Xu; Hongxuan Wu; Peijie Shen; Xianzhang Jiang; Xueduan Chen; Jinxin Lin; Jianzhong Huang; Feng Qi
Journal:  J Ind Microbiol Biotechnol       Date:  2020-01-28       Impact factor: 3.346

6.  Pareto Optimality Explanation of the Glycolytic Alternatives in Nature.

Authors:  Chiam Yu Ng; Lin Wang; Anupam Chowdhury; Costas D Maranas
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

7.  Improvement of NADPH bioavailability in Escherichia coli by replacing NAD(+)-dependent glyceraldehyde-3-phosphate dehydrogenase GapA with NADP (+)-dependent GapB from Bacillus subtilis and addition of NAD kinase.

Authors:  Yipeng Wang; Ka-Yiu San; George N Bennett
Journal:  J Ind Microbiol Biotechnol       Date:  2013-09-19       Impact factor: 3.346

8.  Synthetic biology guides biofuel production.

Authors:  Michael R Connor; Shota Atsumi
Journal:  J Biomed Biotechnol       Date:  2010-08-12

9.  In silico model-driven cofactor engineering strategies for improving the overall NADP(H) turnover in microbial cell factories.

Authors:  Meiyappan Lakshmanan; Kai Yu; Lokanand Koduru; Dong-Yup Lee
Journal:  J Ind Microbiol Biotechnol       Date:  2015-08-08       Impact factor: 3.346

10.  Metabolic regulation of Escherichia coli and its gdhA, glnL, gltB, D mutants under different carbon and nitrogen limitations in the continuous culture.

Authors:  Rahul Kumar; Kazuyuki Shimizu
Journal:  Microb Cell Fact       Date:  2010-01-27       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.